IL210220A - An antibody that binds to the epitope of a p2x7 receptor, its uses and its kit - Google Patents

An antibody that binds to the epitope of a p2x7 receptor, its uses and its kit

Info

Publication number
IL210220A
IL210220A IL210220A IL21022010A IL210220A IL 210220 A IL210220 A IL 210220A IL 210220 A IL210220 A IL 210220A IL 21022010 A IL21022010 A IL 21022010A IL 210220 A IL210220 A IL 210220A
Authority
IL
Israel
Prior art keywords
epitope
antibody
receptor
kit
binding
Prior art date
Application number
IL210220A
Other languages
English (en)
Hebrew (he)
Other versions
IL210220A0 (en
Original Assignee
Biosceptre Aust Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008903451A external-priority patent/AU2008903451A0/en
Application filed by Biosceptre Aust Pty Ltd filed Critical Biosceptre Aust Pty Ltd
Publication of IL210220A0 publication Critical patent/IL210220A0/en
Publication of IL210220A publication Critical patent/IL210220A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL210220A 2008-07-04 2010-12-23 An antibody that binds to the epitope of a p2x7 receptor, its uses and its kit IL210220A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2008903451A AU2008903451A0 (en) 2008-07-04 Composite peptide
PCT/AU2009/000869 WO2010000041A1 (en) 2008-07-04 2009-07-03 Anti- p2x7 peptides and epitopes

Publications (2)

Publication Number Publication Date
IL210220A0 IL210220A0 (en) 2011-03-31
IL210220A true IL210220A (en) 2016-04-21

Family

ID=41465424

Family Applications (2)

Application Number Title Priority Date Filing Date
IL210220A IL210220A (en) 2008-07-04 2010-12-23 An antibody that binds to the epitope of a p2x7 receptor, its uses and its kit
IL232394A IL232394A (en) 2008-07-04 2014-04-30 A peptide, its uses and a kit containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL232394A IL232394A (en) 2008-07-04 2014-04-30 A peptide, its uses and a kit containing it

Country Status (12)

Country Link
US (3) US8597643B2 (OSRAM)
EP (1) EP2318438B1 (OSRAM)
JP (2) JP5701752B2 (OSRAM)
KR (1) KR101701300B1 (OSRAM)
CN (1) CN102143978B (OSRAM)
AU (1) AU2009266430B2 (OSRAM)
BR (1) BRPI0915367B8 (OSRAM)
CA (1) CA2729868C (OSRAM)
ES (1) ES2610225T3 (OSRAM)
IL (2) IL210220A (OSRAM)
NZ (1) NZ590146A (OSRAM)
WO (1) WO2010000041A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1961767B1 (en) 2001-01-17 2012-03-07 Biosceptre International Limited Diagnosis and treatment of cancers and other conditions
US8293491B2 (en) 2007-09-14 2012-10-23 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
JP5670192B2 (ja) 2007-09-14 2015-02-18 バイオセプター・インターナショナル・リミテッド 新規ｐ２ｘ７エピトープ
AU2009266430B2 (en) 2008-07-04 2014-08-14 Biosceptre International Limited Anti- P2X7 peptides and epitopes
JP5936067B2 (ja) 2009-08-20 2016-06-15 バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド 抗ｐ２ｘ７受容体抗体およびその断片
EP2516470B1 (en) 2009-12-24 2018-02-07 Biosceptre (Aust) Pty Ltd Antibodies to non-functional oligomeric p2x7 receptors
AU2011301153B2 (en) 2010-09-10 2014-11-27 Biosceptre International Limited Companion animal treatments
ES2689272T3 (es) 2011-07-01 2018-11-13 Biosceptre (Aust) Pty Ltd Terapia de combinación
US20180037650A1 (en) * 2015-04-02 2018-02-08 Biosceptre (Uk) Limited Pain Treatment
US12121539B2 (en) * 2015-09-11 2024-10-22 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
CA3035835A1 (en) 2016-10-21 2018-04-26 Biosceptre (Uk) Limited Cytotoxic particles
US20250282844A1 (en) * 2021-04-08 2025-09-11 Biosceptre (Aust) Pty Ltd Methods for controlling immune cell activity
JP2025531030A (ja) * 2022-09-14 2025-09-19 バイオセプター （オースト） プロプライエタリー・リミテッド 免疫細胞のインビボ検出
CN120166997A (zh) * 2022-09-14 2025-06-17 生物权威(澳大利亚)有限责任公司 检测免疫细胞的方法
EP4587465A1 (en) * 2022-09-14 2025-07-23 Biosceptre (Aust) Pty Ltd Enrichment of engineered immune cells

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920765A1 (en) 1991-03-12 1992-09-23 Scripps Research Inst Cell surface receptors homologous to coagulation factors v¹and viii
EP0760850A1 (en) 1994-05-27 1997-03-12 Glaxo Group Limited P2x RECEPTORS (PURINOCEPTOR FAMILY)
JPH11510393A (ja) 1995-08-09 1999-09-14 インスティチュート ナショナル ドゥ ラ セント エト ドゥ ラ リサーチェ メディカル 白血病マーカーとしておよび乳癌の予後において有用な単離された核酸分子
WO1997041222A1 (en) 1996-04-30 1997-11-06 Smithkline Beecham P.L.C. HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
US6303338B1 (en) * 1996-08-16 2001-10-16 Human Genome Sciences, Inc. Pancreas-derived plasminogen activator inhibitor
US6306393B1 (en) * 1997-03-24 2001-10-23 Immunomedics, Inc. Immunotherapy of B-cell malignancies using anti-CD22 antibodies
JP3885177B2 (ja) 1997-03-26 2007-02-21 大塚製薬株式会社 ヒト遺伝子
US6133434A (en) * 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
PT1086223E (pt) * 1998-06-01 2009-11-03 Agensys Inc Novos antigénios transmembranares em serpentina expressos em cancros humanos e suas utilizações
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
EP1157038A4 (en) 1999-02-26 2005-01-19 Smithkline Beecham Corp CLONING OF A P2Y-LIKE 7TM RECEPTOR (AXOR17)
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
WO2001030964A2 (en) 1999-10-22 2001-05-03 Lifespan Biosciences, Inc. Anti-cancer nucleic acid and protein targets
AU2001274902A1 (en) * 2000-12-06 2002-06-18 Linex Technologies, Inc. Efficient sharing of capacity by remote stations using circuit switching and packet switching
AUPR201500A0 (en) 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
EP1961767B1 (en) * 2001-01-17 2012-03-07 Biosceptre International Limited Diagnosis and treatment of cancers and other conditions
TWI329648B (en) * 2001-09-03 2010-09-01 Intreat Pty Ltd Diagnosis and treatment of cancers and other conditions
WO2004092384A2 (en) 2003-04-17 2004-10-28 Affectis Pharmaceuticals Ag Means and methods for diagnosing and treating affective disorders
WO2006136004A1 (en) * 2005-05-05 2006-12-28 Medicure International Inc. Inhibition of atp-mediated, p2x7 dependent pathways by pyridoxal-5-phosphaste and vitamin b6 related compounds
US7767789B2 (en) * 2005-06-02 2010-08-03 University Hopitals of Cleveland Truncated proteins as cancer markers
EP1929305A2 (en) 2005-08-31 2008-06-11 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
WO2008043146A1 (en) * 2006-10-10 2008-04-17 Biosceptre International Limited Antibodies against non functional p2x7 receptor
US8067550B2 (en) * 2006-10-10 2011-11-29 Biosceptre International Limited Hybridomas producing antibodies against non functional P2X7 receptor
US8293491B2 (en) * 2007-09-14 2012-10-23 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
JP5670192B2 (ja) * 2007-09-14 2015-02-18 バイオセプター・インターナショナル・リミテッド 新規ｐ２ｘ７エピトープ
AU2009266430B2 (en) 2008-07-04 2014-08-14 Biosceptre International Limited Anti- P2X7 peptides and epitopes
JP5936067B2 (ja) * 2009-08-20 2016-06-15 バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド 抗ｐ２ｘ７受容体抗体およびその断片
EP2516470B1 (en) 2009-12-24 2018-02-07 Biosceptre (Aust) Pty Ltd Antibodies to non-functional oligomeric p2x7 receptors
WO2011131472A1 (en) 2010-04-22 2011-10-27 Institut Gustave Roussy Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
AU2011301153B2 (en) 2010-09-10 2014-11-27 Biosceptre International Limited Companion animal treatments
ES2689272T3 (es) 2011-07-01 2018-11-13 Biosceptre (Aust) Pty Ltd Terapia de combinación

Also Published As

Publication number Publication date
KR20110031222A (ko) 2011-03-24
BRPI0915367A2 (pt) 2015-11-03
ES2610225T3 (es) 2017-04-26
US9328155B2 (en) 2016-05-03
IL232394A0 (en) 2014-06-30
US20160199442A1 (en) 2016-07-14
BRPI0915367B1 (pt) 2020-10-13
EP2318438B1 (en) 2016-11-02
KR101701300B1 (ko) 2017-02-01
NZ590146A (en) 2012-09-28
US8597643B2 (en) 2013-12-03
IL232394A (en) 2016-04-21
AU2009266430A1 (en) 2010-01-07
EP2318438A1 (en) 2011-05-11
US20140135475A1 (en) 2014-05-15
IL210220A0 (en) 2011-03-31
AU2009266430A8 (en) 2011-03-10
CN102143978A (zh) 2011-08-03
US10238716B2 (en) 2019-03-26
CA2729868C (en) 2018-07-10
BRPI0915367B8 (pt) 2021-05-25
AU2009266430B2 (en) 2014-08-14
WO2010000041A1 (en) 2010-01-07
JP2015038144A (ja) 2015-02-26
JP5701752B2 (ja) 2015-04-15
CA2729868A1 (en) 2010-01-07
US20110110959A1 (en) 2011-05-12
EP2318438A4 (en) 2012-11-21
CN102143978B (zh) 2015-02-18
JP2011526249A (ja) 2011-10-06

Similar Documents

Publication Publication Date Title
IL210220A (en) An antibody that binds to the epitope of a p2x7 receptor, its uses and its kit
ZA201003578B (en) Wise binding antibodies and epitopes
ZA201003496B (en) Monoclonal antibody capable of binding to anexelekto,and use thereof
IL234081B (en) Antibody binds cd3–epsilon in different species
IL201340A (en) Antidote 3dc - epsilon in various species
SG10201400426XA (en) Antibodies to ox-2/cd200 and uses thereof
IL200012A0 (en) Anti-robo4 antibodies and uses therefor
LT2436696T (lt) Anti-beta-amiloido antikūnas ir jo panaudojimas
PT2374883T (pt) Anticorpo anti-cd4
IL205355A0 (en) Anti- hepcidin antibodies and uses thereof
SG10201601279SA (en) Monoclonal Antibody STRO-4
PL2146745T3 (pl) Pięcioswoiste przeciwciało
EP2138576A4 (en) ANTI-CLAUDIN-4 ANTIBODY
PT2510011E (pt) Anticorpos monoclonais que se ligam a b7h6 e suas utilizações
IL201983A (en) Antibody against pan nrpa
IL200168A0 (en) Monoclonal anti-cxcl13 antibodies
IL205073A0 (en) Anti-bst2 antibody
IL202996A0 (en) Anti-mcp-1 antibodies, compositions, methods and uses
ZA201103941B (en) Anti-ferroportin 1 monoclonal antibodies and uses thereof
GB0812277D0 (en) Antibody and uses thereof
HK1147764A (en) Wise binding antibodies and epitopes
HK1145505A (en) Anti-chikungunya monoclonal antibodies and uses thereof
AU2007905018A0 (en) Novel P2x7 epitopes
ZA200905136B (en) Anti-robo4 antibodies and uses therefor
HK1141036A (en) Humanized antibodies which bind to a (1-42) globulomer and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed